Pharmacy Benefit Services adjusted pre-tax income growth measures the year-over-year change in issuer-defined pre-tax adjusted income from operations for the pharmacy benefit operating segment.
Evernorth reported a 27% decline in Pharmacy Benefit Services pre-tax adjusted income from operations in the second quarter of 2026, to $609M from $833M.
Revenue growth did not translate into profit growth
PBM adjusted revenue rose 8% while adjusted pre-tax income declined 27%.
Cigna attributed the pressure primarily to client-focused initiatives, including large contract renewals, and other customer-focused initiatives.
Adjusted income remains issuer-defined
The measure follows Cigna's segment reconciliation and should not be treated as standardized PBM operating income across peers.
Read it with PBM adjusted revenue growth and Evernorth pre-tax margin.
Primary source: Cigna Q2 2026 Form 10-Q.
Part of the Pharmacy Benefit & Specialty Care Economics
See It in Company Research
These companies are examples of how the concept is reported or discussed in public filings. Definitions can differ by issuer; these links open company research rather than a normalized metric comparison.
- CIOpen operating-model research →10 of 10 reviewed concepts in Pharmacy Benefit & Specialty Care EconomicsPBM versus specialty and care growth4 of 4 bridge concepts supportedContinue through this bridge:PBM Adjusted Revenue GrowthSpecialty & Care Income GrowthSpecialty & Care Revenue Growth
Continue Research
Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.
Compare pharmacy services economics
Compare PBM profit growth against adjusted revenue growth and client-focused contract economics.
Explore more topics in the Financial Research Encyclopedia.